Overview
The Library has signed up to a Read & Publish agreement with ACM Open. The deal began on the 1st January 2023 and will end on the 31st December 2025.
Read
Access to all subscription content.
Publish
Unlimited open access for QUB corresponding authors publishing research articles and conference proceedings in any ACM Open journal.
Overview
The Library has signed up to a Read & Publish agreement with the American Chemical Society. The deal began on the 1st January 2022 and will end on the 31 December 2024.
Read
Full access to the publishers' journal portfolio.
Publish
Unlimited open access publishing for all research articles in all ACS journals, including ACS Omega, JACS Au, the ACS Au collection, and all ACS hybrid journals. (Includes both Hybrid and Fully OA titles)
QUB corresponding authors only.
Overview
The Library has signed up to a Read & Publish agreement with the American Physiological Society. The deal began on the 1st January 2021 and will end on the 31 December 2024.
Read
Full access to the publishers' 12 hybrid journal titles.
Publish
Unlimited open access publishing for QUB corresponding authors in the publishers' 12 hybrid journal titles.
Full OA titles not included in the deal.
Overview
The Library has signed up to a Read & Publish agreement with Bioscientifica. The deal began on the 1st January 2021 and will end on the 31 December 2024.
Read
Access to all paywalled content (including archives).
Publish
Unlimited open access publishing for QUB corresponding authors in Bioscientifica's four hybrid journals.
Overview
The Library has signed up to a Read & Publish agreement with BMJ. The deal began on the 1st January 2022 and will end on the 31 December 2024.
Read
Access to BMJ's standard collection plus BMJ innovations, BMJ leader, European Journal of Hospital Pharmacy, Journal of Investigative Medicine, BMJ Supportive and Palliative Care, and the International Journal of Gynecological Cancer.
Publish
Unlimited open access publishing for QUB corresponding authors in BMJ's hybrid journal titles.
Original research articles only.
Overview
The Library has signed up to a Read & Publish agreement with Brill. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Read
Access to the latest full Brill journal collection.
Publish
Uncapped open access publishing for QUB corresponding authors in all of Brill’s journals. Includes research and review articles, as well as conference papers.
Overview
The Library has signed up to a Read & Publish agreement with Bristol University Press. The deal began on the 1st January 2022 and will end on the 31st December 2023.
Read
Access to BUP's complete journal portfolio.
Publish
Unlimited open access publishing for QUB corresponding authors in BUP's hybrid journals.
Overview
The Library has signed up to a Read & Publish agreement with Cambridge University Press. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Read
Access to the CUP journals collection.
Publish
Queen’s corresponding authors can publish articles with immediate open access in any CUP Gold or Hybrid journal: click here for a list of Cambridge journals covered by the agreement.
Open Access publishing will be unlimited for 2022.
Overview
The Library has signed up to a Read & Publish agreement with Cold Spring Harbor Laboratory Press. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Read
Access to the complete collection of CSHL Press journals.
Publish
Unlimited open access publishing of research articles for QUB corresponding authors in four research titles: Genes & Development, Genome Research, RNA, and Learning & Memory.
Overview
The Library has signed up to a three year Read & Publish agreement with The Company of Biologists. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Read
Access to the complete collection of journals.
Publish
Unlimited open access publishing for QUB corresponding authors in 3 hybrid journals: Development, Journal of Cell Science, The Journal of Experimental Biology + two fully OA journals, Disease Models & mechanisms, Biology Open.
Overview
The Library has signed up to a Read & Publish agreement with De Gruyter. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to De Gruyter's 344 journal titles.
Publish
Open Access publishing for QUB corresponding authors in De Gruyter's hybrid journals.
Uncapped OA publishing in hybrid journals from 1st January 2022 for the remainder of the agreement.
Review articles also included with research articles from 2022.
Overview
The Library has signed up to a Read & Publish agreement with Elsevier. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Read
Read access is provided to all titles within the collection subscribed to by Queen's.
Publish
Unlimited open access publishing for QUB corresponding authors publishing in Elsevier's Core-hybrid, Cell Press, and the Lancet titles (hybrid only).
Discover which Elsevier journals are participating in the agreement here.
Authors publishing in Elsevier's fully open access journals will have to pay an article processing charge (APC). Queen's corresponding authors are entitled to a 15% discount on the APC. Please visit Queen's Gold Open Access page to see if your research funder has provided Queen's with funds to pay your APC.
Overview
The Library has renewed its Read & Publish deal with the European Respiratory Society. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to the European Respiratory Journal.
Publish
Unlimited open access publishing for QUB corresponding authors in the European Respiratory Journal, ERJ Open Research, & European Respiratory Review.
Overview
The Library has signed up to a Read & Publish agreement with Future Science Group. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to FSG's 17 hybrid and 16 open access journals.
Publish
Unlimited open access publishing for QUB corresponding authors in all FSG journals. All article types (excluding Drug Evaluation articles and content/research sponsored or funded by pharma/biotech).
Overview
The Library has signed up to a Read & Publish agreement with the Geological Society. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to the full journal collection.
Publish
Unlimited open access publishing for QUB corresponding authors in 6 hybrid journals and 3 hybrid book series.
Overview
The Library has signed up to a Read & Publish agreement with the Institute of Physics (IOP). The deal began on the 1st January 2020 and will end on the 31st December 2023.
Read
Access to all subscription journals, owned by IOP, which offer a hybrid open access option. In addition, the agreement also includes selected journals which are published by IOP Publishing on behalf of their society partners.
Publish
Open Access publishing for QUB corresponding authors publishing in a IOP hybrid journal. Click here for the list of hybrid titles that are eligible.
Some IOP full OA titles included. Please enter "Institute of Physics" in the search box below to discover the full OA IOP titles.
Overview
The Library has signed up to a Read & Publish agreement with Karger. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to the complete journal collection (69 subscription, 35 OA journals).
Publish
Unlimited open access publishing for QUB corresponding authors in any hybrid or fully OA journal.
Overview
The Library has signed up to a Read & Publish agreement with the Microbiology Society. The deal began on the 1st January 2020 and will end on the 31st December 2024.
Read
Access to all Microbiology society journals.
Publish
Unlimited open access publishing for QUB corresponding authors.
Overview
The Library has signed up to a Read & Publish agreement with Optica Publishing Group. This deal began on the 1st January 2022 and will end on the 31st December 2024.
Read
Access to the Optica journals collection.
Publish
Queen’s corresponding authors can publish research & review articles with immediate open access in Optica journals (excludes Optics and Photonics News, and both partnered and legacy journals).
Open Access publishing will be unlimited for 2022
Overview
The Library has signed up to a Read & Publish agreement with the Oxford University Press. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to OUP's full collection.
Publish
QUB corresponding authors can publish a Research or Review article with immediate open access in OUP Hybrid & Gold journals.
Unlimited publishing secured for 2022-23.
Overview
The Library has signed up to a Read & Publish agreement with PLOS. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to the full collection.
Publish
Unlimited open access publishing for QUB corresponding authors in all PLOS journals.
Overview
The Library has signed up to a Read & Publish agreement with Portland Press. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to all journals.
Publish
Unlimited open access publishing for QUB corresponding authors in all 7 Portland Press journals.
Overview
The Library has signed up to a Read & Publish agreement with the Radiological Society of North America. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Read
Access to the society's two flagship titles: (i) Radiology (ii) Radiographics.
Publish
Unlimited open access publishing for QUB corresponding authors in Radiology.
Overview
The Library has signed up to a Read & Publish agreement with Rockefeller University Press. The deal began in March 2020 and will end on the 31st December 2023.
Read
Access to RUP's three hybrid journals: Journal of Cell Biology, Journal of Experimental Medicine, Journal of General Physiology
Publish
Unlimited open access publishing for QUB corresponding authors in RUP journals.
Overview
The Library has signed up to a Read & Publish agreement with the Royal College of General Practitioners. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Read
Access to the British Journal of General Practice.
Publish
Unlimited open access publishing for QUB corresponding authors in the British Journal of General Practice and BJGP Open.
Research articles only.
Overview
The Library has signed up to a Read & Publish agreement with the Royal Irish Academy. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Read
Access to all journals.
Publish
Unlimited open access publishing for QUB corresponding authors in the publishers 6 subscription journals.
Overview
The Library has signed up to a Read & Publish agreement with the Royal Society. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to all 8 hybrid journals.
Publish
Unlimited open access for QUB corresponding authors publishing in all journals.
Overview
The Library has signed up to a Read & Publish agreement with the Royal Society Of Chemistry. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Read
Access to the RSC's journal collection.
Publish
OA article allocation - not unlimited open access publishing.
Only available to QUB corresponding authors publishing in a RSC Hybrid journal.
All peer reviewed article types are covered in this agreement which fall into three main categories: full papers, communications, and reviews.
Overview
The Library has signed up to a Read & Publish agreement with SAGE. The deal began on the 1st January 2020 and ended on the 31st December 2022. *Negotiations ongoing*.
Read
Access to SAGE's journal collection.
Publish
Unlimited open access publishing for QUB corresponding authors in SAGE hybrid journals.
Overview
The Library has signed up to a Read & Publish agreement with the Springer. The deal began on the 1st January 2021 and ended on the 31st December 2022. Negotiations ongoing. More information available here.
Read
Access to all 38 academic journals from the Nature journals agreement.
Publish
Open access publishing for QUB corresponding authors in more than 2,000 Springer hybrid journals.
Overview
The Library has signed up to a Read & Publish agreement with Taylor & Francis. The deal began on the 1st January 2021 and will end on the 31st December 2023.
Read
Access to Taylor & Francis group's portfolio of journals.
Publish
Open Access publishing for QUB corresponding authors in T&F's Open Select (hybrid) journals.
Research articles only.
Not unlimited publishing, consortium article cap applies.
Overview
The Library has signed up to a Read & Publish agreement with Thieme. The deal began on the 1st January 2022 and will end on the 31st December 2023.
Read
Access to Thieme's Medical and Chemistry collections.
Publish
Unlimited open access publishing for QUB corresponding authors in all Thieme hybrid journals.
Original and review articles covered.
Overview
The University Library is signed up to a transformative journals agreement with Wiley. The deal began on 1st January 2020 and will end on 31 December 2023.
Read
Access to the Wiley journal collection.
Publish
Queen's 'Responsible Corresponding Authors' (RCA) can publish primary research and review articles in any of Wiley's and Hindawi's fully gold open access journals and Wiley’s hybrid (subscription-based) journals which offer open access.
Not unlimited open access publishing.
Overview
The Library has signed up to a Read & Publish agreement with Wolters Kluwer. The deal began on the 1st January 2022 and will end on the 31 December 2024.
Read
The agreement provides read and publish rights for the complete Total Access Collection of over 300 LWW medical and nursing journals including a large number of society-owned journals, available via the Ovid platform.
Publish
Capped open access publishing for QUB corresponding authors only.
Title exclusions:
Journal of the American College of Surgeons and titles within the JCO bundle are excluded from this Agreement.
Titles excluded: Journal of the American College of Surgeons, JCO Clinical Cancer Informatics, JCO Global Oncology, Journal of Clinical Oncology, JCO Oncology Practice, JCO Precision Oncology.